Wealthcare Advisory Partners’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-17
Closed -$1K – 568
2021
Q1
$1K Buy
+17
New +$642 ﹤0.01% 1949
2020
Q2
– Sell
-3
Closed – – 336
2020
Q1
$0 Hold
3
– – ﹤0.01% 1469
2019
Q4
$0 Hold
3
– – ﹤0.01% 1376
2019
Q3
$0 Hold
3
– – ﹤0.01% 1334
2019
Q2
$0 Hold
3
– – ﹤0.01% 1299
2019
Q1
$0 Sell
3
-6
-67% -$105 ﹤0.01% 1207
2018
Q4
$0 Sell
9
-6
-40% -$155 ﹤0.01% 1196
2018
Q3
$1K Hold
15
– – ﹤0.01% 1160
2018
Q2
$1K Hold
15
– – ﹤0.01% 1162
2018
Q1
$1K Hold
15
– – ﹤0.01% 995
2017
Q4
$1K Sell
15
-20
-57% -$1.61K ﹤0.01% 963
2017
Q3
$3K Buy
+35
New +$2.48K ﹤0.01% 706

Other funds holding ADNT

Wealthcare Advisory Partners's ADNT Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Adient (ADNT) in Q2 2021, closing a stake of 17 shares — an estimated $1K sold.

Wealthcare Advisory Partners first reported a position in ADNT in Q3 2017 and held it in 12 quarters. The position peaked at $3K in Q3 2017. 290 funds tracked by Wall St. Rank hold ADNT as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Adient position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 17 Adient shares in Q2 2021, an estimated $1K.
  • Wealthcare Advisory Partners first reported a position in Adient in Q3 2017 and held it in 12 quarters.
  • Wealthcare Advisory Partners's Adient position peaked at $3K in Q3 2017.
  • 290 funds tracked by Wall St. Rank held Adient as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.